PLEASANTON, Calif. and PARIS, Nov. 6, 2023 /PRNewswire/ -- OWKIN and 10x Genomics, Inc. (TXG), announce they have entered into an agreement to add 10x Genomics spatial omics and single-cell ...

The integration of multi-omics approaches in drug discovery is rapidly gaining momentum, offering a more comprehensive understanding of disease biology and paving the way for personalized medicine. A ...

An IOM committee will review the published literature to identify appropriate evaluation criteria for tests based on "omics" technologies (e.g. genomics, epigenomics, proteomics, metabolomics) that ...

When Integrated DNA Technologies (IDT) was founded in 1987 by Dr. Joseph Walder, he set his sights on a bold company vision. He believed that synthetic nucleic acids—known as oligonucleotides (oligos) ...

The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).

In recognition of Pancreatic Cancer Awareness Month, join us to explore how cutting-edge technologies are transforming our understanding of pancreatic ductal adenocarcinoma (PDAC), one of the most ...

Type 2 diabetes (T2D) is a major chronic metabolic disease worldwide and is especially prevalent in older adults. Although many synthetic drugs are ...

A new computational tool helps researchers map molecular interactions, revealing the pathways associated with disease. Understanding how molecules interact inside our cells is key to uncovering how ...

The ‘Omics Days’ conference was held over three days, with a rich and focused program, covering various Omics research topics at the forefront of AFBI’s current scientific interest and corporate ...